Month: February 2018
-
A.I./Image Analysis Diagnose Eye, Lung Diseases
Researchers developed more efficient computational tools with artificial intelligence (A.I.) to diagnose retinal diseases and pneumonia by analyzing retinal scans and X-ray images.
-
Highly Stretchable Sensors Devised for Wearable Devices
Engineers in Canada developed graphene sensors with a great deal of flexibility that can measure fine human movements and minute functions for wearable medical devices, and be made with an economical process.
-
Making a Success of Your Webpage
A web page serves so much more purpose than merely acting as a place for people to buy your products.
-
Gut-Brain Therapies Biotech Raises $66M in New Funds
A 2 year-old biotechnology enterprise discovering new treatments for disease that harness signals between the gut and brain is raising $66 million its second venture financing round.
-
Precision Cancer Drug Shown Effective in Adults, Children
Results from 3 clinical trials show most cancer patients given an experimental drug that directly addresses a specific genetic mutation respond to the treatments, despite their cancers occurring in a variety of organs.
-
The Science Behind Business Intelligence: Nine Analytics Software You Need to Use
By understanding the science behind the business intelligence software, you will be able to take advantage of the information available and improve your business.
-
Coalition Standardizes Chronic Kidney Disease Tests
A group of medical lab companies, medical centers, and not-for-profit groups developed standardized testing protocols for chronic kidney disease, which participants expect will help more people diagnose the condition earlier.
-
Trial Shows Treatment Desensitizes Peanut Allergies
A large-scale clinical trial shows a preventive treatment desensitizes peanut allergies in children, with most participants able to tolerate substantial amounts of peanut proteins after 1 year.
-
Pharma, Biotech Partner on Neuro Therapies in $1.1B Deal
Voyager Therapeutics, a developer of gene therapies for neurological disorders, is collaborating with drug maker AbbVie on treatments for diseases resulting from the build-up of damaging proteins in the brain, as in Alzheimer’s disease.
-
RNA Vaccine Shows Promise with Infant Viral Diseases
A vaccine using synthetic RNA, with protein instructions transcribed from one’s genetic code, is shown in tests with lab animals to protect against infections from cytomegalovirus, a virus affecting infants and transplant recipients.